Hindustan Unilever Share Price: Q1 FY27 Results And What It Means For Retail Investors

Nidhi Thakur

July 28, 2026

Key Takeaways

Hindustan Unilever's Q1 FY27 revenue rose 10.2% YoY to Rs 17,149 crore, signaling robust demand across categories.
Net profit fell 3% YoY to Rs 2,673 crore due to a one-off tax credit in the previous quarter, affecting earnings sentiment.
USG growth was 10%, driven by volumes and price, with EBITDA margins around 23% despite input cost pressures.
The FY27 outlook remains constructive with portfolio and channel transformation supporting volume-led growth.

Investors tracking the Hindustan Unilever Share Price will want to parse the Q1 FY27 numbers carefully. Hindustan Unilever reported revenue from operations of Rs 17,149 crore for the quarter, up 10.2% year-on-year from Rs 15,552 crore in the year-ago period. Net profit declined 3% to Rs 2,673 crore, a dip attributed to a one-off tax credit recorded in the prior quarter. EBITDA rose to Rs 3,947 crore, an 8% year-on-year gain, while the EBITDA margin eased 40 basis points to 23%. These headlines set the tone for the Hindustan Unilever quarterly results and frame how investors think about the Hindustan Unilever share price trajectory. As we unpack the quarter, we see a company delivering revenue growth while navigating margin pressures, which can influence near-term price action and long-term value realization.

Understanding Hindustan Unilever Share Price And Q1 FY27 Revenue Growth

Hindustan Unilever's underlying sales growth (USG) for the quarter stood at 10%, indicating that both volumes and price increases contributed to the top line. The company highlighted a robust performance across segments, with Home Care delivering 14% USG–the highest in three years. This strength was underpinned by disciplined market development and consumer-centric innovations that reinforced market leadership while preserving volume resilience.

Beauty and Wellbeing grew 12% USG, supported by high-single-digit UVG. In Hair Care, double-digit USG reflected ongoing momentum in Premium Hair Care formats, while Skin Care and Colour Cosmetics posted high-single-digit USG, driven by double-digit growth in Premium Skin Care. Personal Care rose 4% USG, mainly through pricing given persistent palm oil inflation. Skin Cleansing registered mid-single-digit USG, with Premium Bars delivering double-digit growth and maintaining leadership in Body Wash.

In Foods, USG was 7%, supported by mid-single-digit UVG and continued momentum in Lifestyle Nutrition and Coffee. Premium Tea posted low-single-digit UVG, while Coffee delivered double-digit, volume-led growth, aided by RTD and Bru Gold scaling up. Notably, Boost crossed the Rs 1,000 crore annual turnover milestone, while Horlicks Superfoods and RTD continued to gain traction.

Metric	Value	Comment
Revenue from operations	Rs 17,149 crore	Up 10.2% YoY
Net profit (PAT)	Rs 2,673 crore	Down 3% YoY due to one-off tax credit in previous quarter
EBITDA	Rs 3,947 crore	Up 8% YoY
EBITDA Margin	23.0%	Down 40 bps YoY
USG	10%	Underlying sales growth

Download App Now

Hindustan Unilever Earnings: A Closer Look At The Q1 FY27 Performance

The Hindustan Unilever earnings were characterized by robust topline expansion coupled with a margin backdrop shaped by input costs and a tax-related one-off in the previous quarter. The 10% USG confirms that price realization and volume growth are still feeding into the revenue line, while the margin compression reflects persistent commodity pressures (notably palm oil) and the operational discipline needed to sustain profitability in a volatile inflationary environment.

From an investor's viewpoint, the earnings narrative remains positive in terms of revenue growth, but the interesting dynamic is how HUL plans to navigate margin headwinds while continuing to invest in its portfolio and channel transformation. The quarter's numbers suggest that while the Hindustan Unilever earnings are supported by pricing, the company must balance this with volume-led growth to protect margins over the coming quarters.

Download App Now

Hindustan Unilever Quarterly Results: Segment Highlights And Margins

Dissecting the quarterly results by segment reveals a broad-based growth story with a mix of volume-led and price-driven gains. Home Care led the pack with 14% USG, marking its strongest growth in three years. The segment benefited from disciplined market development and consumer-centric innovations that preserved leadership even as consumption displayed resilience.

Beauty & Wellbeing advanced 12% USG, with Hair Care posting double-digit growth on the back of Premium Hair Care formats and ongoing expansion into future formats. Skin Care and Colour Cosmetics delivered high-single-digit USG, underpinned by double-digit growth in Premium Skin Care. Personal Care rose 4% USG, led by pricing against palm oil inflation, and Skin Cleansing registered mid-single-digit USG, with Premium Bars delivering double-digit growth and maintaining leadership in Body Wash.

In Foods, USG reached 7%. Lifestyle Nutrition and Coffee drove momentum, while Premium Tea posted a low-single-digit USG. Coffee delivered double-digit growth, supported by RTD products and Bru Gold scaling up. Boost’s Rs 1,000 crore milestone highlights the continued strength of the nutrition beverage platform, with Horlicks Superfoods and RTD continuing to see encouraging traction.

From a margin perspective, the consolidated EBITDA stood at Rs 3,947 crore, with margin around the mid-20s–illustrating the ongoing balance between revenue expansion and input cost pressures. The company indicated that commodity volatility remains a challenge in the near term, but the FY27 outlook remains better than FY26, anchored by portfolio and channel transformation and a focus on volume-led revenue growth.

Investors can view these segmental outcomes as evidence that Hindustan Unilever's diversification across Home Care, Beauty & Wellbeing, Personal Care and Foods continues to support a resilient top line even as margins adjust to cost pressures. The 10% USG implies that the company has the right demand drivers in place to offset inflationary pressures and maintain a positive trajectory through FY27.

For deeper stock-level analysis and to tailor your decision to your risk tolerance and investment horizon, you can consult Swastika's Sarthi AI stock assistant, which provides institutional-level research on stocks and indices to retail investors. Swastika's Sarthi AI stock assistant.

What The Outlook For FY27 Means For Hindustan Unilever Share Price

The management's outlook for FY27 indicates that the year should be better than FY26, supported by portfolio and channel transformation. While commodity volatility and inflationary pressures may persist in the near term, the company expects consolidated EBITDA margin to remain around the current guided range. This suggests that the Hindustan Unilever share price could respond to progress on portfolio optimization, channel expansion, and continued volume-led growth more than to a single quarter's numbers.

From a strategic standpoint, Hindustan Unilever's emphasis on pricing discipline to counter palm oil inflation and on innovations across Home Care, Beauty & Wellbeing, and Foods aligns with a growth-at-scale thesis. The Boost milestone and continued traction in Horlicks Superfoods and RTD lines underpin a longer-term consumer health and nutrition story that could support earnings growth beyond FY27. The investor takeaway is that the stock may trade on a blend of growth momentum and cost headwinds, with the potential for multiple expansion should volume growth continue to outpace cost pressures.

As you evaluate the Hindustan Unilever Share Price trajectory, consider the following: the quarter demonstrates resilience in revenue growth; the earnings bottom line was impacted by a one-off tax credit in the prior quarter; margins remain a watchpoint as input costs stay elevated; and the long-term competitive strengths–portfolio, distribution, and brand equity–offer upside if volume growth sustains momentum.

Frequently Asked Questions

What were Hindustan Unilever's Q1 FY27 revenue and net profit, and how did they change year-over-year?

Revenue from operations rose to Rs 17,149 crore, up 10.2% YoY, while net profit declined 3% YoY to Rs 2,673 crore due to a one-off tax credit in the previous quarter.

What drove Hindustan Unilever's revenue growth in Q1 FY27?

Underlying sales growth (USG) was 10%, driven by both volume growth and price realization, with all major segments contributing to the top line.

How did Hindustan Unilever's margins perform in Q1 FY27?

EBITDA rose 8% to Rs 3,947 crore, but EBITDA margin declined 40 basis points to 23% year-on-year.

Which Hindustan Unilever segments led growth in Q1 FY27?

Home Care led with 14% USG, Beauty & Wellbeing 12%, Foods 7%, and Personal Care 4% USG, with each segment supported by innovations, pricing, and volume growth.

What is the FY27 outlook for Hindustan Unilever and how might it affect the share price?

FY27 is expected to be better than FY26, supported by portfolio and channel transformation. Commodity volatility and inflationary pressures are expected to persist in the near term, but EBITDA margin is anticipated to stay around the guided range. These dynamics could influence Hindustan Unilever share price through revenue growth momentum and margin management.

What is Swastika's Sarthi AI stock assistant and how can it help investors?

Swastika's Sarthi AI stock assistant provides institutional-level research on stocks and indices to retail investors and can help you interpret earnings data, margins, and growth drivers in a structured way.

Conclusion

Hindustan Unilever's Q1 FY27 results illustrate a robust topline growth story underpinned by a 10% USG, even as margins are tested by input cost pressures. For the retail investor, the takeaway is that the Hindustan Unilever share price may react more to progress on volume-led growth and portfolio transformation than to a single quarter's profit fluctuation. The company remains well-positioned across its core categories, with Boost, Horlicks Superfoods, and RTD assets illustrating durable demand and trajectory.

Next step: Use a framework that weighs growth momentum against margin normalization. Look for ongoing progress on pricing discipline, category leadership, and distribution expansion as signals the company can sustain a favorable earnings path through FY27 and beyond. A practical mental model is to view Hindustan Unilever as a diversified consumer growth engine that can withstand near-term inflationary headwinds if it continues to invest in its core brands and channel reach. This approach can help you assess potential Hindustan Unilever share price movements in the context of changing consumer demand and commodity cycles.

Open your trading and demat account here

Reference :

1 : Economictimes

DISCLAIMER:

^{The information contained herein are strictly confidential and are meant solely for the information of the recipient and shall not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written permission of Swastika Investmart Ltd. (“SIL”). The contents of this document are for information purpose only. This document is not an investment advice and must not alone be taken as the basis for an investment decision. Before taking any decision to invest, the recipient of this document must read carefully the Red Herring Prospectus (“RHP”) issued to know the details of IPO and various risks and uncertainties associated with the investment in the IPO of the Company. All recipients of this document must before acting on the given information/details, make their own investigation and apply independent judgment based on their specific investment objectives and financial position. They can also seek appropriate professional advice from their own legal and tax consultants, advisors, etc. to understand the risks and investment considerations arising from such investment. The investor should possess appropriate resources to analyze such investment and the suitability of such investment to such investor’s particular circumstances before making any decisions on the investment. The Investor shall be solely responsible for any action taken based on this document. SIL shall not be liable for any direct or indirect losses arising from the use of the information contained in this document and accept no responsibility for statements made otherwise issued or any other source of information received by the investor and the investor would be doing so at his/her/its own risk. The information contained in this document should not be construed as forecast or promise or guarantee or assurance of any kind. The investors are not being offered any assurance or guaranteed or fixed returns on their investments. The users of this document must bear in mind that past performances if any, are not indicative of future results. The actual returns on investment may be materially different than the past. Investments in Securities market products and instruments including in the IPO of the Company are highly risky and they are generally not an appropriate avenue for someone with limited resources/ limited investment and low risk tolerance. Such Investments are subject to market risks including, without limitation, price, volatility and liquidity and capital risks. Therefore, the users of this document must carefully consider all the information given in the RHP including the risks factors before making any investment in the Equity Shares of the Company.Swastika Investmart Ltd or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither Swastika Investmart Ltd nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. Swastika Investment Ltd may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the Subject Company or third party in connection with the Research Report.CORPORATE & ADMINISTRATIVE OFFICE - 48, Jaora Compound, M.Y.H. Road, Indore - 452 001 | Phone 0731 - 6644000 Compliance Officer: Dimple Soni. Email: compliance@swastika.co.in Phone: (0731) 6644 241 Swastika Investmart Limited, SEBI Reg. No. : NSE/BSE/MSEI: INZ000192732 Merchant Banking: INM000012102 Investment Adviser: INA000009843 MCX/NCDEX: INZ000072532 CDSL/NSDL: IN-DP-115-2015 RBI Reg. No.: B-03-00174 IRDA Reg. No.: 713. Research Analyst Registration Number: INH000024073}